Besides, inhibiting CES3 enhanced NSCLC cell lipid accumulation (Figure 3), indicating that CES3 was an important player in NSCLC cell proliferation, invasion and lipid metabolism. Here, CES3 is linked to non-small cell lung carcinoma.